Chemring (CMN1) AI Stock Analysis
Chemring
(BX Swiss:CMN1)
No summary available
Chemring (CMN1) vs. iShares MSCI Switzerland ETF (EWL)
- Market Cap
- CHF 1.53B
- Dividend Yield
- 1.40%
- Average Volume (3M)
- 800
- Price to Earnings (P/E)
- 46.3
- Beta (1Y)
- 0.39
- Revenue Growth
- -8.70%
- EPS Growth
- -25.59%
- Country
- Switzerland
- Employees
- 2,700
- Sector
- Industrials
- Sector Strength
- 63
- Industry
- Aerospace & Defense
Chemring Business Overview & Revenue Model
Company Description
Chemring Group Plc engages in the manufacture of technology products and services for the aerospace, defense, and security markets. It operates through the following segments: Sensors & Information; and Countermeasures & Energetics. The Sensors & Inf...
Chemring Earnings Call Summary
The earnings call indicated strong performance and growth potential, particularly in the Energetics segment with a record order book and improved operational efficiency. However, challenges remain in the Sensors & Information segment due to delays in government spending and increased costs in Norway. The company is confident in its long-term growth strategy.
Q4-2025 Updates
Positive Updates
Negative Updates
Company Guidance
During the call, Chemring reported a robust financial performance for the fiscal year ending October 31, 2025, despite short-term headwinds such as decreased U.K. government order placements. The company achieved a record order book of GBP 1.3 billion, up 32% year-on-year, with order intake rising 20% to GBP 781 million. Group revenue increased by 2% to GBP 498 million, and operating margin improved by 50 basis points to 14.8%. Earnings per share rose to 19.4p, and cash conversion was strong at 114%. The Countermeasures & Energetics segment saw a 17% revenue growth, with operating profit up 37% and margins increasing to 19.1%. Meanwhile, the Sensors & Information segment faced challenges, with revenue down 18% and operating profit falling 25%. Despite these challenges, operating margins were maintained at nearly 18%. The Board declared a final dividend of 5.3p, bringing the total dividend to 8p, up 3%. Looking ahead, Chemring is targeting significant growth in its Energetics and Sensors & Information segments, with strategic investments and acquisitions supporting its long-term revenue goal of GBP 1 billion by 2030.
Chemring Peers Comparison
Overall Rating
GB:BA75Outperform
GB:QQ68.9Neutral
GB:CHRT68Neutral
GB:BAB62Neutral
GB:SRP62Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| GB:BA | 75Outperform | GBP 60.55B | 29.57 | 17.49% | 1.83% | 7.20% | 8.54% |
| GB:QQ | 69Neutral | GBP 2.75B | 27.20 | 19.34% | 2.04% | -0.47% | ― |
| GB:CHRT | 68Neutral | GBP 652.04M | 27.69 | 13.59% | 1.27% | 13.46% | 15.89% |
| Sector * | 63Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
| GB:BAB | 62Neutral | GBP 4.99B | 24.11 | 31.57% | 0.73% | 7.17% | -14.18% |
| GB:SRP | 62Neutral | GBP 2.75B | 18.75 | 17.55% | 1.61% | 1.20% | 221.80% |
* Industrials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| CH:CMN1 | Chemring (CHG) | 6.21 | 0.07 | 1.07% | |
| GB:BA | Bae Systems Plc | 2070.00 | 240.91 | 13.17% | |
| GB:BAB | Babcock International | 1024.00 | -183.29 | -15.18% | |
| GB:CHRT | Cohort plc | 1412.00 | 123.25 | 9.56% | |
| GB:SRP | Serco Group plc | 288.20 | 41.09 | 16.63% | |
| GB:QQ | QinetiQ Group plc | 540.50 | 69.43 | 14.74% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.